ANSWER
RECEPTOR WHICH ARE ACTIVATED BY DIMERIZATION
INCLUDE
- Receptor Tyrosine Kinase (RTK):
Contains intrinsic tyrosine kinase activity (EGFR, VEGFR). Growth
factors such as insulin, epidermal growth factor (EGF), and
platelet-derived growth factor bind to the extracellular domains of
transmembrane receptors that have tyrosine kinase domains present
within their intracellular domains.The receptor tyrosine kinase is
monomeric and enzymatically inactive in the absence of the growth
factor. The binding of EGF to the extracellular domain causes the
receptor to dimerize and undergo cross-phosphorylation and
activation.
- Receptor Serine/Threonine Kinase:
Contains intrinsic serine/threonine kinase activity
(TGF-βR)-Receptor serine/threonine kinases ( RSKs) are
transmembrane proteins of the plasma membrane and are characterized
by extracellular ligand‐binding domains and cytoplasmic kinase
domains.The serine/threonine kinase receptors are typified by the
receptors for transforming growth factor β (TGFβ), a dimeric ligand
that exerts its effects through receptors composed of two different
subunits designated type I and type II. Each possesses
serine/threonine kinase activity. Both classes of receptor
protomers are required for mediating the signaling response to
ligand binding. The type II TGFβ receptor (TβR-II) exists as a
constitutively active dimer and is responsible for the initial
interaction with TGFβ, as the type I receptor (TβR-I) cannot bind
TGFβ in the absence of TβR-II.
- CYTOKINE RECEPTOR:Cytokine
receptors activate many signaling pathways generally by means of
phosphotyrosine residues, which are recognized by SH2 domains on
the signaling molecules. The STATs contain a carboxy-terminal SH2
domain, an SH3-like domain and several conserved amino-terminal
regions, and a conserved region in the middle of the protein that
binds DNA. Tyrosine phosphorylation of a carboxy-terminal site
mediates homo- or heterodimerization through the SH2 domains,
triggering movement to the nucleus and DNA binding.A native
un-liganded receptor in complex with a JAK is in a catalytically
inactive latent state. Receptor dimerization/oligomerization due to
ligand binding results in the juxtapositioning of the JAKs, which
are in the vicinity through either homo- or heterodimeric
interactions. The recruitment of JAKs appears to result in their
phosphorylation, either via autophosphorylation and/or cross
phosphorylation by other JAKs or via other families of tyrosine
kinases. This activation is presumed to result in increased JAK
activity. Activated JAKs then phosphorylate receptors on target
tyrosine sites. The phosphotyrosine sites on the receptors can then
serve as docking sites that allow the binding of other SH2-domain
containing signaling molecules such as STATs, Src-kinases, protein
phosphatases and other adaptor signaling proteins such as Shc, Grb2
and phosphatidylinositol 3-kinase (PI3K).